Harmony Biosciences Holdings, Inc.
Customers
3
3 active
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Mar 31, 2026
10-Q filed 2026-05-07
Customers 3
Companies HRMY discloses as major customers, as a share of HRMY revenue. 3 active, 0 lapsed.
| Company | % of HRMY revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| Accredo Health Group, Inc Non-SEC Accredo Health Group, Inc |
Named | — | 3M 2026-03-31 | +2.0pp | Active | 10-Q 2026-05-07 |
Accredo Health Group, Inc. (“Accredo”), which accounted for 41% of gross accounts receivable; Accredo Health Group, Inc. accounted for 36% of gross product revenue; and PANTHERx Specialty Pharmacy LLC accounted for 26% of gross product revenue. As of December 31, 2025, three customers accounted for 100% of gross accounts receivable, Accredo Health Group, Inc. (“Accredo”), which accounted for 45% of gross accounts receivable; | ||||||
| Caremark LLC Non-SEC Caremark LLC |
Named | — | 3M 2026-03-31 | Active | 10-Q 2026-05-07 | |
Caremark LLC (“CVS Caremark”), which accounted for 33% of gross accounts receivable; and PANTHERx Specialty Pharmacy LLC (“Pantherx”), which accounted for 26% of gross accounts receivable. Caremark LLC accounted for 38% of gross product revenue; | ||||||
| PANTHERx Specialty Pharmacy LLC Non-SEC PANTHERx Specialty Pharmacy LLC |
Named | — | 3M 2026-03-31 | Active | 10-Q 2026-05-07 | |
Caremark LLC (“CVS Caremark”), which accounted for 33% of gross accounts receivable; and PANTHERx Specialty Pharmacy LLC (“Pantherx”), which accounted for 26% of gross accounts receivable. Accredo Health Group, Inc. accounted for 36% of gross product revenue; and PANTHERx Specialty Pharmacy LLC accounted for 26% of gross product revenue. | ||||||
Alerts are coming
Get an email when HRMY's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.